@article{UBHD-68778467,
  author={Goldschmidt, Hartmut and Mai, Elias K. and D{\"u}rig, Jan and Scheid, Christoph and Weisel, Katja C. and Kunz, Christina and Bertsch, Uta and Hielscher, Thomas and Merz, Maximilian and Munder, Markus and Lindemann, Hans-Walter and H{\"u}gle-D{\"o}rr, Barbara and Tichy, Diana and Giesen, Nicola and Hose, Dirk and Seckinger, Anja and Huhn, Stefanie and Luntz, Steffen P. and Jauch, Anna and Elmaagacli, Ahmet and Rabold, Bernhard and Fuhrmann, Stephan and Brossart, Peter and Goerner, Martin and Bernhard, Helga and Hoffmann, Martin and Hillengaß, Jens and Raab, Marc-Steffen and Blau, Igor-Wolfgang and H{\"a}nel, Mathias and Salwender, Hans},
  title={Response-adapted lenalidomide maintenance in newly diagnosed myeloma},
  subtitle={results from the phase III GMMG-MM5 trial},
  year={2020},
  pages={1853-1865},
  language={eng},
  issn={1476-5551},
  volume={34},
  number={7},
  note={Gesehen am 09.09.2021},
  journal={Leukemia},
  doi={10.1038/s41375-020-0724-1},
  url={https://doi.org/10.1038/s41375-020-0724-1},
  library={UB},
}